XENON PHARMACEUTICALS INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $550.0M | $175.7M |
| FY2022 | — | $721.5M | $57.2M |
| FY2023 | — | $927.9M | $148.6M |
| FY2024 | — | $754.9M | $142.7M |
| FY2025 | — | $581.8M | $199.2M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $550.0M | $175.7M |
| FY2022 | — | $721.5M | $57.2M |
| FY2023 | — | $927.9M | $148.6M |
| FY2024 | — | $754.9M | $142.7M |
| FY2025 | — | $581.8M | $199.2M |